Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
$4.25
$4.27
$2.35
$4.95
N/AN/A13,344 shs4,657 shs
BPZZF
Boston Pizza Royalties Income Fund
$11.51
-0.6%
$11.53
$10.50
$12.80
N/AN/A930 shs478 shs
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$0.67
-5.6%
$0.83
$0.50
$4.67
$36.71M0.7647,761 shs216,111 shs
Brinker International, Inc. stock logo
EAT
Brinker International
$47.61
-0.8%
$47.02
$28.23
$51.72
$2.11B2.461.29 million shs772,594 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
0.00%-2.30%-9.78%+11.84%+65.37%
BPZZF
Boston Pizza Royalties Income Fund
+0.47%+1.49%-1.24%+1.22%+0.70%
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
-3.19%-0.27%-19.95%+32.96%-82.32%
Brinker International, Inc. stock logo
EAT
Brinker International
+3.94%+6.10%+4.25%+22.68%+22.11%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
N/AN/AN/AN/AN/AN/AN/AN/A
BPZZF
Boston Pizza Royalties Income Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
3.9499 of 5 stars
3.42.00.04.21.91.71.3
Brinker International, Inc. stock logo
EAT
Brinker International
3.8602 of 5 stars
2.13.00.01.82.50.83.8

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
N/AN/AN/AN/A
BPZZF
Boston Pizza Royalties Income Fund
N/AN/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
2.75
Moderate Buy$9.751,351.76% Upside
Brinker International, Inc. stock logo
EAT
Brinker International
2.18
Hold$44.19-7.19% Downside

Current Analyst Ratings

Latest EAT, ALSSF, BPZZF, and CARA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/24/2024
Brinker International, Inc. stock logo
EAT
Brinker International
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$46.00 ➝ $50.00
4/18/2024
Brinker International, Inc. stock logo
EAT
Brinker International
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$48.00 ➝ $50.00
4/16/2024
Brinker International, Inc. stock logo
EAT
Brinker International
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$47.00 ➝ $48.00
4/12/2024
Brinker International, Inc. stock logo
EAT
Brinker International
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$36.00 ➝ $39.00
4/11/2024
Brinker International, Inc. stock logo
EAT
Brinker International
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $55.00
4/10/2024
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00
3/28/2024
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00
3/19/2024
Brinker International, Inc. stock logo
EAT
Brinker International
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$44.00 ➝ $48.00
3/6/2024
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $10.00
3/5/2024
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00
2/1/2024
Brinker International, Inc. stock logo
EAT
Brinker International
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$43.00 ➝ $46.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
N/AN/AN/AN/AN/AN/A
BPZZF
Boston Pizza Royalties Income Fund
N/AN/AN/AN/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
$20.97M1.75N/AN/A$1.05 per share0.64
Brinker International, Inc. stock logo
EAT
Brinker International
$4.13B0.51$6.83 per share6.97($3.24) per share-14.69

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
N/A$1.064.01N/AN/AN/AN/AN/A
BPZZF
Boston Pizza Royalties Income Fund
N/A$1.269.16N/AN/AN/AN/A5/8/2024 (Estimated)
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
-$118.51M-$2.18N/AN/AN/A-565.21%-122.10%-89.64%5/20/2024 (Estimated)
Brinker International, Inc. stock logo
EAT
Brinker International
$102.60M$3.4113.9611.530.753.63%-113.41%7.07%4/30/2024 (Confirmed)

Latest EAT, ALSSF, BPZZF, and CARA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
Brinker International, Inc. stock logo
EAT
Brinker International
$1.15N/A-$1.15N/AN/AN/A  
3/4/202412/31/2023
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
-$0.57-$0.59-$0.02-$0.59$2.34 million$3.00 million    
1/31/2024Q2 2024
Brinker International, Inc. stock logo
EAT
Brinker International
$0.94$0.99+$0.05$1.04$1.08 billion$1.07 billion

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
N/AN/AN/AN/AN/A
BPZZF
Boston Pizza Royalties Income Fund
$0.827.09%N/A65.00%N/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
N/AN/AN/AN/AN/A
Brinker International, Inc. stock logo
EAT
Brinker International
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
N/AN/AN/A
BPZZF
Boston Pizza Royalties Income Fund
N/AN/AN/A
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
N/A
4.54
4.43
Brinker International, Inc. stock logo
EAT
Brinker International
N/A
0.36
0.30

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
22.50%
BPZZF
Boston Pizza Royalties Income Fund
25.97%
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
44.66%
Brinker International, Inc. stock logo
EAT
Brinker International
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alsea, S.A.B. de C.V. stock logo
ALSSF
Alsea
79,271N/AN/ANot Optionable
BPZZF
Boston Pizza Royalties Income Fund
N/AN/AN/ANot Optionable
Cara Therapeutics, Inc. stock logo
CARA
Cara Therapeutics
5554.66 million52.36 millionOptionable
Brinker International, Inc. stock logo
EAT
Brinker International
64,32344.23 million43.56 millionOptionable

EAT, ALSSF, BPZZF, and CARA Headlines

SourceHeadline
Brinker International (NYSE:EAT) Price Target Raised to $50.00Brinker International (NYSE:EAT) Price Target Raised to $50.00
marketbeat.com - April 24 at 12:54 PM
Earnings Preview: Brinker International (EAT) Q3 Earnings Expected to DeclineEarnings Preview: Brinker International (EAT) Q3 Earnings Expected to Decline
zacks.com - April 23 at 11:07 AM
Brinker International (EAT) to Release Quarterly Earnings on TuesdayBrinker International (EAT) to Release Quarterly Earnings on Tuesday
marketbeat.com - April 23 at 6:32 AM
5 Solid Restaurant Stocks to Buy as March Sales Rise5 Solid Restaurant Stocks to Buy as March Sales Rise
zacks.com - April 22 at 9:31 AM
George Felix of Chili’s meets customers where they areGeorge Felix of Chili’s meets customers where they are
nrn.com - April 21 at 11:16 PM
Toni Brinker, founder and CEO of One CommunityUSA in Dallas, dies at 74Toni Brinker, founder and CEO of One CommunityUSA in Dallas, dies at 74
msn.com - April 21 at 11:16 PM
Hussman Strategic Advisors Inc. Has $2.72 Million Stock Holdings in Brinker International, Inc. (NYSE:EAT)Hussman Strategic Advisors Inc. Has $2.72 Million Stock Holdings in Brinker International, Inc. (NYSE:EAT)
marketbeat.com - April 21 at 3:11 PM
Brinker International (NYSE:EAT) PT Raised to $50.00Brinker International (NYSE:EAT) PT Raised to $50.00
americanbankingnews.com - April 20 at 5:26 AM
Brinker International (EAT) Stock Moves -0.15%: What You Should KnowBrinker International (EAT) Stock Moves -0.15%: What You Should Know
msn.com - April 19 at 7:03 PM
Are Investors Undervaluing Brinker International (EAT) Right Now?Are Investors Undervaluing Brinker International (EAT) Right Now?
zacks.com - April 19 at 10:40 AM
Brinker International (NYSE:EAT) PT Raised to $50.00 at Evercore ISIBrinker International (NYSE:EAT) PT Raised to $50.00 at Evercore ISI
marketbeat.com - April 18 at 11:20 AM
Brinker International, Inc. (NYSE:EAT) Sees Significant Decrease in Short InterestBrinker International, Inc. (NYSE:EAT) Sees Significant Decrease in Short Interest
americanbankingnews.com - April 18 at 6:48 AM
Brinker International (NYSE:EAT) Price Target Increased to $48.00 by Analysts at Jefferies Financial GroupBrinker International (NYSE:EAT) Price Target Increased to $48.00 by Analysts at Jefferies Financial Group
americanbankingnews.com - April 17 at 4:10 AM
Brinker International, Inc. (NYSE:EAT) Short Interest UpdateBrinker International, Inc. (NYSE:EAT) Short Interest Update
marketbeat.com - April 16 at 5:16 PM
BRINKER INTERNATIONAL, INC. TO HOST THIRD QUARTER FISCAL 2024 EARNINGS CALLBRINKER INTERNATIONAL, INC. TO HOST THIRD QUARTER FISCAL 2024 EARNINGS CALL
finance.yahoo.com - April 16 at 5:10 PM
Brinker International (NYSE:EAT) Price Target Raised to $48.00 at Jefferies Financial GroupBrinker International (NYSE:EAT) Price Target Raised to $48.00 at Jefferies Financial Group
marketbeat.com - April 16 at 12:04 PM
5 Restaurant Stocks to Buy on Strong Sales in March5 Restaurant Stocks to Buy on Strong Sales in March
zacks.com - April 16 at 9:26 AM
Reviewing Yoshiharu Global (NASDAQ:YOSH) and Brinker International (NYSE:EAT)Reviewing Yoshiharu Global (NASDAQ:YOSH) and Brinker International (NYSE:EAT)
americanbankingnews.com - April 16 at 2:02 AM
Brinker International, Inc. (EAT) Is a Trending Stock: Facts to Know Before Betting on ItBrinker International, Inc. (EAT) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com - April 15 at 10:06 AM
Its All Happening: Chilis® Introduces a New Espresso Martini to Its Menu with Help from Reality Stars Scheana Shay and Katie MaloneyIt's All Happening: Chili's® Introduces a New Espresso Martini to Its Menu with Help from Reality Stars Scheana Shay and Katie Maloney
prnewswire.com - April 15 at 9:00 AM
Morgan Stanley Boosts Brinker International (NYSE:EAT) Price Target to $39.00Morgan Stanley Boosts Brinker International (NYSE:EAT) Price Target to $39.00
americanbankingnews.com - April 14 at 3:26 AM
Brinker International (NYSE:EAT) PT Raised to $39.00 at Morgan StanleyBrinker International (NYSE:EAT) PT Raised to $39.00 at Morgan Stanley
marketbeat.com - April 12 at 1:26 PM
Stifel Nicolaus Raises Brinker International (NYSE:EAT) Price Target to $55.00Stifel Nicolaus Raises Brinker International (NYSE:EAT) Price Target to $55.00
marketbeat.com - April 11 at 9:17 AM
Peregrine Capital Management LLC Sells 202,016 Shares of Brinker International, Inc. (NYSE:EAT)Peregrine Capital Management LLC Sells 202,016 Shares of Brinker International, Inc. (NYSE:EAT)
marketbeat.com - April 10 at 9:49 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Alsea logo

Alsea

OTCMKTS:ALSSF
Alsea, S.A.B. de C.V. operates restaurants in Latin America and Europe. It operates fast food, coffee shops, casual food, and family restaurants under the Domino's Pizza, Starbucks, Burger King, Chili's, PF Chang's, Italianni's, The Cheesecake Factory, Vips, The gate, Foster's Hollywood, Archies, Ginos, T.G.I. Fridays, Vips Europe, Vips Smart, Ole Mole, and Clay Hear brands. The company was incorporated in 1997 and is headquartered in Mexico City, Mexico.

Boston Pizza Royalties Income Fund

OTCMKTS:BPZZF
Boston Pizza Royalties Income Fund operates as a limited purpose open-ended trust. The company, indirectly through Boston Pizza Royalties Limited Partnership, owns trade-marks used by Boston Pizza International Inc. It operates and franchises Boston Pizza restaurants. The company was founded in 1964 and is based in Richmond, Canada. Boston Pizza Royalties Income Fund operates as a subsidiary of James Treliving Holdings Ltd.
Cara Therapeutics logo

Cara Therapeutics

NASDAQ:CARA
Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.
Brinker International logo

Brinker International

NYSE:EAT
Brinker International, Inc., together with its subsidiaries, engages in the ownership, development, operation, and franchising of casual dining restaurants in the United States and internationally. It operates and franchises Chili's Grill & Bar and Maggiano's Little Italy restaurant brands. The company also operates virtual brands, It's Just Wings. Brinker International, Inc. was founded in 1975 and is headquartered in Dallas, Texas.